DE60322918D1 - Verfahren für die photodynamische diagnose von gefässerkrankungen - Google Patents

Verfahren für die photodynamische diagnose von gefässerkrankungen

Info

Publication number
DE60322918D1
DE60322918D1 DE60322918T DE60322918T DE60322918D1 DE 60322918 D1 DE60322918 D1 DE 60322918D1 DE 60322918 T DE60322918 T DE 60322918T DE 60322918 T DE60322918 T DE 60322918T DE 60322918 D1 DE60322918 D1 DE 60322918D1
Authority
DE
Germany
Prior art keywords
photodynamic
iminochlorinaspartic
remedies
acceptable salt
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322918T
Other languages
English (en)
Inventor
Isao Sakata
Susumu Nakajima
Yoshinori Nakae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamamatsu Photonics KK
Original Assignee
Hamamatsu Photonics KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamamatsu Photonics KK filed Critical Hamamatsu Photonics KK
Application granted granted Critical
Publication of DE60322918D1 publication Critical patent/DE60322918D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60322918T 2002-06-25 2003-06-25 Verfahren für die photodynamische diagnose von gefässerkrankungen Expired - Lifetime DE60322918D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002185296A JP4394334B2 (ja) 2002-06-25 2002-06-25 脈管病に関する光物理化学的診断・治療薬
PCT/JP2003/008016 WO2004000308A1 (ja) 2002-06-25 2003-06-25 脈管病に関する光物理化学的・診断方法

Publications (1)

Publication Number Publication Date
DE60322918D1 true DE60322918D1 (de) 2008-09-25

Family

ID=29996731

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322918T Expired - Lifetime DE60322918D1 (de) 2002-06-25 2003-06-25 Verfahren für die photodynamische diagnose von gefässerkrankungen

Country Status (12)

Country Link
US (1) US20050209298A1 (de)
EP (2) EP1847267A3 (de)
JP (1) JP4394334B2 (de)
KR (1) KR100837136B1 (de)
AT (1) ATE404194T1 (de)
AU (1) AU2003243968B2 (de)
CA (1) CA2490326C (de)
DE (1) DE60322918D1 (de)
DK (1) DK1537867T3 (de)
ES (1) ES2312788T3 (de)
PT (1) PT1537867E (de)
WO (1) WO2004000308A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006085517A1 (ja) * 2005-02-08 2008-06-26 株式会社光ケミカル研究所 クロリン類及びポルフィリン類のpdt用軟膏製剤及び坐剤
US20110160642A1 (en) * 2007-11-15 2011-06-30 Wolfgang Neuberger Pegylated liposomal formulations for photodynamic treatment of inflammatory diseases
JP5179245B2 (ja) * 2008-04-30 2013-04-10 功 阪田 皮膚疾患治療剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
JP3718887B2 (ja) * 1995-10-30 2005-11-24 株式会社光ケミカル研究所 ポルフィリン誘導体とその用途
ATE244244T1 (de) * 1996-10-01 2003-07-15 Wyeth Lederle Japan Ltd Iminochlorinasparaginsaeure-derivate
DE19960705A1 (de) * 1999-12-16 2001-06-21 Laser & Med Tech Gmbh Verfahren und Vorrichtung zur Herstellung eines autologen Immunisierungsimpfstoffes gegen Krebserkrankungen (Tumorvakzine)
JP2003012547A (ja) * 2001-06-27 2003-01-15 Meiji Seika Kaisha Ltd インスリン依存性糖尿病の診断剤および治療剤

Also Published As

Publication number Publication date
ATE404194T1 (de) 2008-08-15
JP2004026717A (ja) 2004-01-29
CA2490326C (en) 2010-09-07
WO2004000308A1 (ja) 2003-12-31
PT1537867E (pt) 2008-10-09
EP1847267A3 (de) 2010-07-07
EP1537867B1 (de) 2008-08-13
ES2312788T3 (es) 2009-03-01
CA2490326A1 (en) 2003-12-31
AU2003243968A1 (en) 2004-01-06
KR100837136B1 (ko) 2008-06-11
US20050209298A1 (en) 2005-09-22
AU2003243968B2 (en) 2008-01-31
KR20050016619A (ko) 2005-02-21
JP4394334B2 (ja) 2010-01-06
EP1537867A1 (de) 2005-06-08
EP1847267A2 (de) 2007-10-24
EP1537867A4 (de) 2006-10-11
DK1537867T3 (da) 2008-11-10

Similar Documents

Publication Publication Date Title
NO20030398L (no) Estere av 5-aminolevulinsyre som fotosensibiliserende midler i fotokjemoterapi
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
DK1558616T3 (da) Meso-substituerede porphyriner
ATE514672T1 (de) Säureadditionssalze von 5-aminolevulinsäure oder derivaten davon
CY1105579T1 (el) Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
NL300176I1 (nl) Esters van 5-aminolevulinezuur als fotosensibiliserende middelen in de fotochemotherapie.
BRPI0510560A (pt) pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
HK1102702A1 (en) Anti-viral uses of borinic acid complexes
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
IL158032A0 (en) Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
WO2020176654A8 (en) Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents
WO2004110151A8 (en) Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
ATE404194T1 (de) Verfahren für die photodynamische diagnose von gefässerkrankungen
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE602004022783D1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
WO2004080273A3 (en) Compositions and methods for diagnosing and treating prostate cancer
DK1359943T3 (da) Biotinderivater og deres konjugater med chelateringsmidler
ATE414083T1 (de) Ocaperidonsalze und pharmazeutische zusammensetzungen, die diese enthalten
CU20090226A7 (es) Derivados de n5-(2-etoxi-etil)-n3-(2-piridinil)-3,5-piperidin-dicarboxamida
EA200401302A1 (ru) Лекарственные средства, содержащие бетамиметики и новое антихолинергическое средство
DE60315597D1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen
WO2005035500A3 (en) Therapeutic agents useful for treating pain

Legal Events

Date Code Title Description
8364 No opposition during term of opposition